# PRANDIN
> **NDA020741** · New Drug Application · Sponsor: GEMINI LABS LLC · Approved 1997-12-22
## Drug
- **FDA Application Number:** NDA020741
- **Application type:** New Drug Application
- **Brand name:** PRANDIN
- **Generic name:** Repaglinide
- **Active ingredients:** REPAGLINIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GEMINI LABS LLC
- **First approval:** 1997-12-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020741)
---
*AI Analytics · CC0 1.0*